KEM:NYE-KraneShares Trust (USD)

ETF | Others |

Last Closing

USD 29.1457

Change

0.00 (0.00)%

Market Cap

USD 3.73M

Volume

521.00

Analyst Target

USD 27.20
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

In order to achieve its investment objective, the fund is actively managed and seeks to mitigate downside risk while attempting to outperform broad emerging markets by dynamically adjusting its allocations between the Underlying ETFs and cash and cash equivalents. Under normal circumstances, the fund will invest at least 80% of its net assets (plus borrowings for investment purposes) in securities of issuers located in emerging markets, including other investments, such as investment companies, that provide investment exposure to such securities.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-28 )

ETFs Containing KEM

BUY 0.00 % 0.95 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 253.21% 99% N/A 95% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 253.21% 99% N/A 95% A
Trailing 12 Months  
Capital Gain 221.34% 99% N/A 94% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 221.34% 99% N/A 94% A
Trailing 5 Years  
Capital Gain 380.95% 85% B 94% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 380.95% 85% B 94% A
Average Annual (5 Year Horizon)  
Capital Gain 1.29% N/A N/A 43% F
Dividend Return 1.76% N/A N/A 34% F
Total Return 0.47% N/A N/A 12% F
Risk Return Profile  
Volatility (Standard Deviation) 16.24% N/A N/A 61% D-
Risk Adjusted Return 10.85% N/A N/A 32% F
Market Capitalization 3.73M 7% C- 3% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.